PARIS: A leading Covid-19 vaccine candidate has shown to safely produce a robust immune response in healthy older adults, its British makers said on Thursday as it released its phase 2 trial results. The vaccine, developed by the University of Oxford and AstraZeneca, produced fewer side effects in people aged 56 and over than in younger people -- a significant finding given that Covid-19 disproportionately causes severe illness among seniors.
Harvey Weinstein. — AFP FileNEW YORK: Harvey Weinstein’s 2020 conviction for sexual assault and rape was...
Liberal Justice Elena Kagan on Sept. 13, 2016. — Slate website WASHINGTON: U.S. Supreme Court justices, wading back...
A representational image of inmates behind jail bars. — Unsplash/FileMOSCOW: A Russian court on Wednesday ordered...
Sudanese soldiers guard the surrounding area of the UNMIS compound in El-Fasher, the administrative capital of North...
US quietly shipped ATACMS missiles to Ukraine. — Report news agencyWASHINGTON: The United States in recent weeks...
US President Joe Biden during his address in California. — AFP FileWASHINGTON: President Joe Biden signed a...
